This site is intended for healthcare professionals only
LoginRegister
JnJ wins USFDA approval for subcutaneous Rybrevant Faspro for EGFR-Mutated NSCLCJohnson and Johnson Gets CDSCO Panel nod for Additional Indication of Ustekinumab solution for...
Roche Itovebi recommended by CHMP for EU approval for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancerEMA Committee recommends EU label update for Roche Phesgo to allow administration outside of...
Bayer new drug application for gadoquatrane accepted for review in ChinaBayer begins Phase I study targeting GPC3 with alpha radiopharmaceutical in advanced hepatocellular...
CDSCO Clears AstraZenecas Imfinzi (Durvalumab) for Additional Cancer Indication in IndiaAstraZeneca Breztri met primary endpoints in Phase III trials in asthma
Not a Nice Time For Nimesulide? DTAB, CDSCO Recommend Stringent RestrictionsNot a Nice Time For Nimesulide? DTAB, CDSCO Recommend Stringent Restrictions
USFDA Closes Inspection of Dr Reddys Srikakulam Facility with VAI ClassificationCDSCO Panel Approves Dr Reddy's Laboratories Protocol Amendment Proposal to study Abatacept
Novartis AG to Exit India Arm in Rs 1,446 Cr Deal, ChrysCapital-Led Consortium Buys 70.68% StakeCDSCO Panel Approves Novartis Healthcare's Protocol Amendment to study Iptacopan
Rajasthan govt set to revive Rajasthan Drugs and PharmaRajasthan govt set to revive Rajasthan Drugs and Pharma
Torrent Pharma Gets Zero USFDA Observations for Dahej PlantNovo Nordisk application for oral Wegovy accepted by USFDA for weight loss
GSK Pharma names Sukanya Choudhury as Regulatory Head, Growth Emerging MarketsGSK Pharma names Sukanya Choudhury as Regulatory Head, Growth Emerging Markets
Sanofi India appoints Haresh Vala as Company Secretary, Compliance OfficerSanofi Consumer Healthcare India Q1 results PAT up 12.9%
CDSCO Panel Seeks Revised Phase IV Trial Protocol for MSN Labs Nelarabine InjectionMSN Laboratories Gets CDSCO Panel Nod To study Brexpiprazole Tablets
X